270 related articles for article (PubMed ID: 33856543)
1. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
Alzahrani ZA; Alghamdi KA; Almaqati AS
Rheumatol Int; 2021 Jun; 41(6):1097-1103. PubMed ID: 33856543
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
[TBL] [Abstract][Full Text] [Related]
5. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
[TBL] [Abstract][Full Text] [Related]
6. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
7. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM
Adv Rheumatol; 2021 Oct; 61(1):60. PubMed ID: 34620246
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in rheumatic disease patients on immunosuppressive agents.
Sharmeen S; Elghawy A; Zarlasht F; Yao Q
Semin Arthritis Rheum; 2020 Aug; 50(4):680-686. PubMed ID: 32512263
[TBL] [Abstract][Full Text] [Related]
9. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
[TBL] [Abstract][Full Text] [Related]
10. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Quartuccio L; Valent F; Pasut E; Tascini C; De Vita S
Joint Bone Spine; 2020 Oct; 87(5):439-443. PubMed ID: 32445935
[TBL] [Abstract][Full Text] [Related]
17. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie
Gamboa-Alonso CM; Figueroa-Parra G; Galarza-Delgado DA
Ann Rheum Dis; 2021 Jan; 80(1):e7. PubMed ID: 32571868
[No Abstract] [Full Text] [Related]
18. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
[TBL] [Abstract][Full Text] [Related]
19. [Severe COVID-19 and outcomes in patients with rheumatic disease].
Galicia-Lucas UJ; Ramírez-Pérez AA
Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):127-132. PubMed ID: 34231984
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
